In a filing to the BSE, the company informed that "Anita Arjundas, vide a letter dated July 1, 2018, submitted her resignation as managing director and director of the company, effective September 30, 2018 as she wishes to pursue her interest in the development/social sector".
The establishment of a market-focused platform will provide information and bespoke home buying solutions for customers across India, the company said in a statement.
Mahindra group's realty firm Mahindra Lifespace Developers Ltd today reported over five fold jump in consolidated net profit at Rs 32.17 crore for the quarter ended September 30, 2016 and will raise up to Rs 300 crore through rights issue.
Income from operations rose marginally to Rs 266.29 crore during the January-March period of the 2015-16 fiscal, compared with Rs 259.11 crore in the same period of 2014-15.
CNBC-TV18's Alexander Mathew caught up with the company's managing director and chief executive officer, Anita Arjundas in an exclusive chat and spoke about the projects that are in the pipeline.
Realty firm Mahindra Lifespace Developers Ltd on Friday reported a 88 percent decline in its consolidated net profit at Rs 21.61 crore for the quarter ended on June 30 due to fall in income.
With a portfolio spanning the mid, premium and luxury housing segments, the company is present across cities like Mumbai, Pune, Nagpur, Gurgaon, Chennai and Hyderabad.
Anita Arjundas, MD & CEO, Mahindra Lifespace feels that Land Acquisition is important to achieve dedicated freight corridors.
The company, this year in June, had launched a new business vertical called 'Happinest', focused on developing affordable housing projects.
In an interview to CNBC-TV18, Anita Arjundas, managing director and chief executive officer, Mahindra Lifespaces says that the company hasn‘t yet considered getting an investor into the listed company.
The premium residential projects in Bangalore, National Capital Region (NCR) and Mumbai would be upwards of Rs 1.5 crore to about Rs 5 crore, says Mahindra Lifespaces MD and CEO Anita Arjundas.